Related Experiment Video
Updated: Jun 29, 2025

07:52
Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts
Published on: April 26, 2018
8.9K
Significantly Elevated FDG Activity in Neurothekeoma
Raisa Amiruddin1, Hongming Zhuang
1From the Department of Radiology, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
Clinical Nuclear Medicine
|March 27, 2024
Summary
This study highlights intense FDG uptake in a rare neurothekeoma case. The rare cutaneous lesion showed abnormal activity in both primary and metastatic sites on PET/CT scans.
Area of Science:
- Oncology
- Radiology
- Dermatology
Background:
- Neurothekeoma is a rare, typically benign cutaneous neoplasm predominantly affecting young individuals.
- Diagnostic imaging plays a crucial role in the management of rare tumors.
Observation:
- A 16-year-old male presented with a primary neurothekeoma on his right shoulder.
- Positron Emission Tomography/Computed Tomography (PET/CT) imaging was performed.
Findings:
- Intense Fluorodeoxyglucose (FDG) uptake was observed at the site of the primary neurothekeoma.
- Two years post-diagnosis, the same patient exhibited abnormal FDG activity in metastatic neurothekeoma within the lung.
Implications:
- This case suggests that FDG PET/CT may be a valuable tool for detecting and monitoring neurothekeoma, including metastatic disease.
- Further research is warranted to explore the utility of FDG PET/CT in the broader clinical context of neurothekeoma management.
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
